Prot#TAK-071-2002: A Randomized, Double-blind, Placebo-Controlled, 2-Period Crossover, Phase 2 Study to Evaluate the Efficacy, Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Oral TAK-071 in Parkinson Disease Patients With Cognitive Impai

Project: Research project

Project Details

StatusFinished
Effective start/end date11/6/20 → 11/6/23

Funding

  • PPD Investigator Services, LLC (TAK-071-2002 // TAK-071-2002)
  • Takeda Development Center Americas, Inc. (TAK-071-2002 // TAK-071-2002)